Leukocyte interleukin injection: Phase I started

Cel-Sci and the U.S. Navy's Naval Medical Center San Diego (NMCSD) began a dose-escalation, U.S. Phase I trial to evaluate 200 and 400 IU perilesional injections of Multikine in up to 15 patients with...